OncoMatch/Clinical Trials/NCT06756074

Reinforced Pancreaticojejunostomy With or Without glubran2

Is NCT06756074 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2) for pancreatic fistula.

Phase 2RecruitingMinia UniversityNCT06756074Data as of May 2026

Treatment: Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2) — Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .

Check if I qualify

Extracted eligibility criteria

Cancer type

Pancreatic Cancer

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify